We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. MCO-010 yielded sustained vision improvements in ...

Nanoscope Therapeutics Inc., a biotechnology company focused on developing and commercializing novel, disease‑agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

Alvin “AJ” Buckley Jr., a student at the Mississippi School for the Blind juggles wrestling and music while looking to the ...

Researchers have identified new drug targets for therapies that could benefit patients with different forms of retinitis pigmentosa and other inherited retinal diseases. Using advanced proteomics ...

With its visibility with the FIFA Men's World Cup coming to town next month, there's a push to make Seattle the Northwest hub ...

WAVES of stress washed over Laura as she psyched herself up for a conversation she had been dreading for days. Just a month ...

Brian Petraits and his family went to the Indy 500. He didn't see a thing. It was an unforgettable experience.

Received FDA Breakthrough Therapy Designation for AAV2-hAQP1Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the ...

Ethiraj College in Chennai grants a full scholarship to visually impaired student J. Kaviya for her undergraduate studies.

U.S. pharmaceutical company Eli Lilly announced on the 25th of last month (local time) interim results from Phase 1 clinical ...